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ABSTRACT
Objectives: The aim of the study was to analyze the changes in cardiac function and myocardial contractility of donor 
and recipient fetuses with twin-to-twin transfusion syndrome (TTTS) subjected to selective laser photocoagulation of the 
communicating vessels (SLPCV), between and after the procedure. Finally, we verified if fetuses with Quintero’s stage I TTTS 
presented with early impairment of myocardial contractility.
Material and methods: We selected 77 consecutive women with twin pregnancies, whose both fetuses survived at least 
seven days post-SLPCV. Myocardial contractility of both fetuses was evaluated ultrasonographically, and their myocardial 
performance indices (Tei-Index values) and shortening fractions (SF) were determined.
Results: In donor fetuses, the Tei-Index values for both right and left ventricle remained within the respective reference 
ranges both before the procedure and during a 7-day follow-up. A significant change in shortening fraction values for the 
left ventricle in recipient fetuses and the right ventricle of in the donors was observed during a 7-day follow-up. 
Conclusions: Comparison of the cardiac parameters of donors and recipients revealed significant differences in Tei-indices 
during the entire follow-up period.
The group with Quintero’s I stage TTTS included 74% of recipient fetuses with abnormal Tei-Index values for the right 
ventricle (mean 0.53).
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INTRODUCTION
Twin-to-twin transfusion syndrome (TTTS) is a severe 
pathology of multifetal monochorionic pregnancy. TTTS 
results from imbalanced blood flow in placental commu-
nicating vessels, which leads to the development of hypo-
volemia in one fetus, referred to as the donor, and hyper-
volemia in another fetus referred to as the recipient. Un-
treated TTTS results in the death of both fetuses in 80–100% 
of the cases [1, 2]. TTTS is diagnosed during pregnancy, on 
the basis of ultrasonographic examination.
The most widespread scale used for classification of the 
severity of TTTS is the staging system proposed by Ruben 
Quintero in 1999 (Tab. 1) [3].
However, the abovementioned scoring system does not 
include parameters describing the myocardial function of 
both fetuses. A few scales for echocardiographic assessment 
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of twin pregnancies have been developed thus far, among 
them the Children’s Hospital of Philadelphia (CHOP) Scoring 
System proposed by Rychik in 2007.
In the CHOP system, each parameter is scored according 
to its presence and severity, with the maximum score of 20. 
Based on the final score, the severity of TTTS is graded 
from I (mild) to IV (most severe). To carry out such a detailed 
assessment, the examiner needs to have adequate experience 
in echocardiography and a sufficient amount of time [4, 5].
Another scoring system is Cardiovascular Profile Score 
by Huhta (2004), which was first used to in order to evaluate 
fetuses from multiple pregnancies by Shah in 2008. Aside 
from Doppler evaluation of blood flow in the umbilical ves-
sels and examination for potential fetal hydrops, also the 
presence of cardiomegaly and myocardial performance are 
considered during the determination of the Cardiovascular 
Profile Score [6].
The Cincinnati Scale proposed by Habli et al. [7]  in 2008 is 
based on the presence and degree of atrioventricular valve 
insufficiency, myocardial thickness and ventricular function 
expressed by myocardial performance index (MPI, Tei-Index).
Finally, Stirnemann Scale was proposed in 2010. Accord-
ing to this scale, the most sensitive marker of fetal heart 
function is the myocardial performance index, Tei-Index [8].
Currently, the treatment of choice in TTTS entails causal 
management, namely selective laser photocoagulation of 
the communicating vessels (SLPCV) [9]. This method in-
volves insertion of a trocar with fetoscope to the amniotic 
cavity (usually to the recipient’s amniotic sac) and identifi-
cation of communicating vessels on the placental surface. 
Subsequently, an optical fiber is inserted through another 
work channel of the trocar to photocoagulate selected 
blood vessels with an infrared laser beam (Fig. 1, 2). 
The aim of the SLPCV is to separate fetal circulations, 
and thus, to change the monochorionic pregnancy into 
a hemodynamically dichorionic pregnancy. Photocoagula-
tion causes immediate closure of the communicating ves-
sels, which contributes to a sudden change of hemodynamic 
conditions. Response to this change is determined by the 
myocardial status of the fetal heart before the procedure and 
Table.1. TTTS severity scale by Ruben Quintero
Symptom/stage I II III IV V
Polyhydramnios/oligohydramnios + + + + +
Absent bladder - + + + +
Abnormal Doppler flows (UA, UV, DV, TV) - - + + +
Generalized hydrops - - - + +
Demise of at least one fetus - - - - +
DV — venous duct; TV — tricuspid valve; UA — umbilical artery;  
UV — umbilical vein
Figure 1. Fetoscopic image: placental vessels
Figure 2. Fetoscopic image: the hand of the fetus
its adaptive potential [2]. Echocardiographic assessment of 
fetal heart before the SLPCV seems to be a prognostic factor 
for further outcome in twin pregnancy [10, 11].
Objectives
The aim of the study was to analyze the changes in 
cardiac function and myocardial contractility of donor and 
recipient fetuses with TTTS subjected to SLPCV, between the 
first day prior to and the seventh day after the procedure. We 
also compared the parameters of cardiac function in donor 
and recipient fetuses before and after the SLPCV. Finally, we 
verified if fetuses with Quintero’s stage I TTTS presented with 
early impairment of myocardial contractility.
MATERIAL AND METHODS
From a group of 142 women subjected to SLPCV due 
to TTTS, 77 consecutive patients with twin pregnancies, in 
whom this procedure was carried out at the Department of 
Obstetrics, Medical University of Gdansk, between January 
1st, 2009 and August 1st, 2015, and whose both fetuses 
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dial contractility was challenging, we excluded these cases 
from the analysis, and their outcomes will be a subject of 
a separate study. This preliminary observation highlights the 
importance of correct early diagnosis and early implementa-
tion of SLPCV in fetuses (especially recipients) with a good 
myocardial condition.
The second group of patients excluded from the study 
were the women in whom digitalis preparations were ad-
ministered after the SLPCV due to the evidence of hydrops 
in donor fetus. It needs to be emphasized that we refrained 
from the administration of digitalis whenever transient tri-
cuspid regurgitation was detected in donor fetus.
Statistical analysis was carried out with Wizard Pro 
1.9.13 software (Evan Miller Chicago, IL). Categorical vari-
ables were expressed as numbers (n) and percentages, and 
continuous variables as means ± standard deviations or me-
dians (minimum-maximum), depending on their distribu-
tion. Normality of the distribution was tested with the Shap-
iro-Wilk test. Paired Student t-test and Wilcoxon signed-rank 
test for repeated measures were used for intragroup com-
parisons, whereas the intergroup comparisons were carried 
out with Student t-test and Mann-Whitney U-test. Multiple 
comparisons were conducted with parametric ANOVA or 
Friedman test. Distributions of categorical variables were 
compared with the chi-square test, McNemar test and Stu-
art-Maxwell test if the changes over time were analyzed. The 
threshold of statistical significance was set at p < 0.05.
RESULTS
The parameters specified in the study protocol were 
determined in the group of 77 patients, before SLPCV and 
during a 7-day follow-up after the procedure. Complete 
results and the outcomes of statistical analysis are presented 
in Table 2.
Myocardial performance indices and shortening fraction 
values for both ventricles in donor and recipient fetuses, 
determined before SLPCV, as well as 1, 3(4) and 7 days post-
procedure, are presented in Table 2. In donor fetuses, the Tei-
Index values for both right and left ventricle remained within 
the respective reference ranges both before the procedure 
and during a 7-day follow-up. In recipient fetuses, the values 
of myocardial performance indices were abnormal before 
SLPCV, improved slightly after the successful procedure 
(with success defined as resolution of TTTS symptoms), but 
remained beyond the respective reference ranges on day 7.
A significant change in shortening fraction values for 
the left ventricle in recipient fetuses and the right ventricle 
in the donors was observed during a 7-day follow-up, as 
shown in Figure 4. 
Comparison of the cardiac parameters of donors and 
recipients revealed significant differences in Tei-indices dur-
ing the entire follow-up period. Moreover, a significant inter-
Figure 3. Tei-Index measurement
survived at least seven days post-procedure were selected. 
Fetal ultrasonographic examination was conducted one day 
before the SLPCV, as well as 1, 3(4) and 7 days thereafter. 
The study patients were qualified to SLPCV based on their 
Quintero’s scores [3, 12, 13].
 Myocardial contractility of both fetuses was evaluated 
ultrasonographically, and their myocardial performance 
indices (Tei-Index values) and shortening fractions (SF) were 
determined. We used the reference values for Tei-Index 
proposed by Falkensammer and Huhta, i.e. 0.38 ± 0.05 and 
0.41 ± 0.05 for the right and left ventricle Tei-Index, respec-
tively. SF was considered normal if it amounted to 25–45%; 
SF between 15% and 25% was interpreted as a mild de-
crease, and SF < 15% as severe cardiac dysfunction [14].  
Each measurement was taken in triplicate, once during 
each of three consecutive cardiac cycles, and arithmetic 
mean from the three measurements was subjected to fur-
ther analysis (Fig. 3). 
Inclusion criteria
The study included women with twin pregnancies com-
plicated with TTTS, who required SLPCV between 16 and 
26 weeks of gestation. Only the patients whose both fetuses 
survived at least seven days post-procedure were subjected 
to the analysis. SLPCV was performed by two operators (MSF 
and KP). Pre- and post-procedural ultrasonographic scans 
were obtained by two ultrasonographers (MSF and KL), us-
ing a standardized protocol of examination.
Exclusion criteria
Two groups of patients were excluded from the hereby 
presented analysis and their results will be presented 
elsewhere.
The first group included women with twin pregnancies, 
in whom digitalis preparations needed to be implemented 
before the SLPCV due to severe cardiac dysfunction in re-
cipient fetus (SF < 15%). As distinguishing between the 
effects of SLPCV and previous pharmacotherapy on myocar-
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group difference in the shortening fraction for the left ven-
tricle was found one day before SLPCV and 3(4) post-SLPCV, 
along with a difference in the shortening fraction for the 
right ventricle on days 3 and 7 (for the latter time point the 
difference was at a threshold of statistical significance) (Fig. 5).
Table 3. Measurements of Tei-Index in Quintero’s first stage
Column Count Mean (range) % of abnormal TEI
TEI LV D 19 0.35 (0.29–0.52) 6%
TEI RV D 19 0.35 (0.24–0.46) 11%
TEI LV R 19 0.44 (0.34–0.8) 37%
TEI RV R 19 0.53 (0.36–1.94) 74%
Table 2. Changes in Tei-Index and SF values for recipient and donor fetuses, observed during a 7-day follow-up after SLPCV. The inner cells 
provide descriptive statistics of the measurements, the outer cells provide p values for changes in time (right-hand column), and for comparison 
of corresponding measures for each pair of donor and recipient (below each pair). Statistically significant differences marked bold
Para- 
meter Ventricle Fetus
Day of follow-up Change in 
time1 day before 1 day after 3(4) days after 7 days after
Tei 
Index
LV
Donor 0.38 (0.30–0.63) 0.35 (0.28–0.68) 0.37 (0.26–0.57) 0.38 (0.26–0.71) p = 0.960
Recipient 0.49 (0.29–0.85) 0.46 (0.24–1.10) 0.45 (0.37–0.80) 0.46 (0.32–0.80) p = 0.833
Don. vs Rec. p < 0.001 p < 0.001 p < 0.001 p < 0.001  
RV
Donor 0.35 (0.20–0.66) 0.35 (0.25–0.74) 0.37 (0.23–0.66) 0.38 (0.25–0.61) p = 0.108
Recipient 0.47 (0.25–1.05) 0.40 (0.25–1.50) 0.46 (1.25–1.09) 0.47 (0.25–1.09) p = 0.659
Don. vs Rec. p < 0.001 p < 0.001 p < 0.001 p = 0.005  
SF
LV
Donor 46.3 ± 5.7 39.7 ± 8.2 41.3 ± 6.8 45.5 ± 5.3 p = 0.463
Recipient 41.30 ± 7.0 45.1 ± 15.1 47.3 ± 11.9 43.4 ± 11.7 p = 0.026
Don. vs Rec. p = 0.022 p = 0.198 p = 0.038 p = 0.507  
RV
Donor 40.8 ± 3.8 37.7 ± 8.6 42.5 ± 8.7 43.4 ± 6.5 p = 0.006
Recipient 37.5 ± 16.3 32.0 ± 16.9 33.2 ± 14.8 35.2 ± 14.9 p = 0.339
Don. vs Rec. p = 0.240 p = 0.240 p = 0.011 p = 0.051  
Figure 5. Changes in Tei-Indices for donor and recipient fetuses 
determined before the SLPCV and during a 7-day post-procedure 
follow-up, and comparison of the Tei-indices in donors and recipients
Figure 4. Changes in shortening fractions for donor and recipient 
fetuses determined before the SLPCV and during a 7-day post-
procedure follow-up, and comparisons of the shortening fractions for 
donors and recipients
To satisfy the third objective of the study, a subset of 
19 (25%) women with Quintero’s stage I TTTS was identi-
fied among the 68 patients whose both fetuses survived at 
least seven days post-procedure. The group with Quintero’s 
I stage TTTS included 74% of recipient fetuses with abnor-
mal Tei-Index values for the right ventricle (mean 0.53) and 
borderline Tei-Index values for the left ventricle (mean 0.44). 
Mean Tei-Index values for the left and right ventricle of do-
nor fetuses were within the respective reference ranges and 
amounted to 0.35 and 0.35, respectively (Tab. 3).
These findings imply that most fetuses with TTTS pre-
sent with anomalies of cardiac function already before the 
manifestation of other pathological features included in the 
most widespread Quintero’s scale, and the right ventricle in 
the recipients is affected more than the left ventricle.
DISCUSSION
SLPCV is the most efficient and effective of currently 
available management options in TTTS. However, it is still 
unclear if all fetuses subjected to SLPCV can fully adjust to 
the new hemodynamic conditions, namely increased blood 
volume in donors and reduced blood volume in recipients.
Fetuses presenting with impaired myocardial function 
before SLPCV have a markedly worse prognosis than the 
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other patients. Thus, improvement of TTTS detection rate 
is of vital importance, as it will enable to implement SLPCV 
at earlier clinical stages.
Previous studies showed that the post-SLPCV decrease 
in recipient’s blood volume might often improve both right 
and left ventricular function, which manifests as an increase 
in myocardial contractility [15, 16].
Our findings are slightly different from those reported 
previously. Habli et al. [10] documented a beneficial effect 
of improved myocardial contractility in recipient fetuses 
on pregnancy outcome and found a positive correlation 
between the post-SLPCV increase in recipient’s contractility 
and the survival after the procedure.
Papanna et al. [11] determined myocardial contractility 
in recipients 24 hours before SLPCV, during the procedure, 
and 12 hours and 24 hours thereafter; the increase in myo-
cardial contractility was observed both during and after 
the procedure.
Stirnemann et al. [17] did not find a significant associa-
tion between the post-SLPCV decrease in myocardial con-
tractility in donor fetuses (defined as an increase in Tei-Index 
or a decrease in SF) and worse outcome of pregnancies 
in which laser photocoagulation was implemented as the 
first-line treatment. In our present study, SLPCV contributed 
to a significant decrease in SF values, for the left ventricle 
in recipients and the right ventricle in donors. However, we 
did not find statistically significant post-procedural changes 
in Tei-indices in either recipients or donors. Our findings 
highlight another practical aspect of myocardial contrac-
tility assessment: analysis of this parameter as early as on 
the first day post-SLPCV can confirm that most, if not all, 
communicating vessels were efficiently closed during the 
procedure. Not infrequently, donor’s amniotic fluid and/or 
urinary bladder still cannot be visualized on the first day 
after SLPCV. However, either a trace of tricuspid regurgita-
tion or a slight decrease in myocardial contractility can be 
already observed in donor fetuses on the first day, pointing 
to enhanced cardiovascular strain and being, in fact, a fa-
vorable prognostic factor. 
As expected, cardiac parameters of donor and recipient 
fetuses differed significantly, both before the SLPCV and 
during a 7-day post-procedural follow-up. 
Future studies with longer follow-up should explain 
how many days are needed for complete normalization of 
myocardial function in recipient fetuses after SLPCV.
We still analyze the data for the two groups of patients 
excluded from our present study due to the administration 
of digitalis preparations. In the first group, digitalis was given 
before the SLPCV because of poor myocardial performance 
in recipient fetuses, and in the second postoperatively, due 
to the evidence of donor hydrops. These groups are going to 
be a subject of separate comprehensive research the results 
of which will be presented in future.
In our opinion, the most interesting finding of this study 
is the observation that nearly 74% of recipient fetuses sub-
jected to SLPCV due to Quintero’s stage I TTTS presented 
with abnormal right ventricular myocardial function, and 
37% of the recipients had both left and right ventricular 
dysfunction. This implies that impairment of myocardial 
contractility precedes manifestation of other characteristic 
features of TTTS included in the Quintero’s scale. Perhaps, 
more careful observation and more accurate measurement 
of myocardial contractility indices, beginning already in 
the 1st trimester, would facilitate earlier identification of 
pregnancies at risk of TTTS, before the changes in amniotic 
fluid volume emerged [18]. Identification of cut-off values 
for Tei-Index distinguishing accurately between the high-risk 
and low-risk group would enable physicians to focus more 
on the former group and to offer them more frequent con-
trol visits (for example, once a week rather than every second 
week). As a result, most cases of TTTS could be identified 
and treated by SLPCV already at Quintero’s stage I. It is 
still unclear whether the laser treatment in Quintero stage 
I is necessary, because only 27% of TTTS cases progress to 
higher stages [19]. Perhaps, the early echocardiographic 
examination could identify the group of fetuses with worse 
cardiac function (i.e. the 37% of fetuses with Quintero’s stage 
I TTTS and both left and right ventricular dysfunction) and 
it would be the same group with worse prognosis which 
needs SLPCV.
The changes in myocardial contractility of fetuses sub-
jected to SLPCV are a subject of ongoing research. The fact 
that a growing number of patients are subjected to this 
procedure raises a possibility to understand better all patho-
genic mechanisms of TTTS, and perhaps also to develop the 
algorithms for pre- and post-SLPCV management, adjusted 
for fetal echocardiographic findings. Definitively, studies 
with long-term follow-up are needed [20]. Accurate prenatal 
diagnostics, including a detailed evaluation of fetal heart 
and its potential pathologies, with no doubt, contributes 
to an improvement of neonatal safety and better quality of 
multimodal perinatal care [21, 22].
CONCLUSIONS
SLPCV improves myocardial contractility in recipient 
fetuses with TTTS.
Improvement of myocardial contractility in twin fetuses 
might be an early prognostic factor for the positive outcome 
of SLPCV. 
In most cases of TTTS (74%), a decrease in myocardial 
contractility of recipient fetuses was observed already at 
Quintero’s stage I.
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